Findibé Damorou
University of Lomé
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Findibé Damorou.
Cardiovascular Journal of Africa | 2012
Soodougoua Baragou; Mohaman Awalou Djibril; Borgatia Atta; Findibé Damorou; Machihude Pio; Agnon Ayelola Koffi Balogou
Objective To determine the prevalence of hypertension and other cardiovascular risk factors in the general adult population of Lome. Methods A cross-sectional household survey was conducted in Lome from October 2009 to January 2010, which focused on hypertension and other cardiovascular risk factors in 2 000 subjects 18 years and older. The World Health Organisation’s STEPS-wise approach on non-communicable diseases was used. During the first session, blood pressure (BP) was measured on three successive occasions, one minute apart, and the mean was recorded. A second measurement session was done three weeks later in patients with BP ≥ 140/90 mmHg during the first session. Hypertension was defined as BP > 140/90 mmHg after the second session, or on antihypertensive treatment. The other risk factors were studied by clinical and blood analysis. Results We found 532 hypertensive patients out of a total of 2 000 subjects. The prevalence of hypertension was 26.6%. The mean age of hypertensive patients was 45 ± 10 years, ranging from 18 to 98 years. The prevalence of other cardiovascular risk factors was: stress (43%), sedentary lifestyle (41%), hypercholesterolaemia (26%), obesity (25.2%), hypertriglyceridaemia (21%), smoking (9.3%), alcohol use (11%) and diabetes (7.3%). Conclusions The prevalence of hypertension and other cardiovascular risk factors in the population of Lome is high. These findings should draw the attention of authorities to define a national policy to combat hypertension and other cardiovascular risk factors.
Clinical Case Reports | 2018
Soulemane Pessinaba; Lantam Sonhaye; Komlavi Yayehd; Latif Amadou; Mohamed Kpélafia; Nsangou Nafissatou; Findibé Damorou
Pulmonary arterial aneurysm is a rare entity with a high mortality if left untreated. Pulmonary arterial hypertension is an important cause of PAAs although other infective and auto‐immune causes must be excluded when an aneurysm is identified.
Clinical Case Reports | 2018
Soulemane Pessinaba; Messan Agbetiafa; Messanvi Aloumon; Komlavi Yayehd; Yawo Molba Dodzi Atti; Findibé Damorou
Belhassen ventricular tachycardia can be characterized by a complete right branch block and a right axial deviation. This type, although rare, must be recognized to properly treat the patient, as verapamil treatment is effective.
The Pan African medical journal | 2017
Soulemane Pessinaba; Yaovi Dodzi Molba; Soodougoua Baragou; Machihude Pio; Yaovi Afassinou; Mohamed Kpélafia; Edem Goeh-Akue; Findibé Damorou
Introduction L’objectif était d’étudier les aspects épidémiologiques, cliniques et évolutifs de l’embolie pulmonaire au CHU Campus de Lomé. Méthodes C’est une étude rétrospective, analytique et descriptive sur une période de 39 mois (1erNovembre 2011- 31 Janvier 2015). Etaient inclus, tous les dossiers des patients hospitalisés dans le service de cardiologie du CHU Campus pour une EP. Résultats La prévalence de l’EP était de 3,1%. Le sex ratio femme/homme était de 2,2. L’âge moyen des patients était de 52,7 ± 14,4 ans. Les facteurs de risque de MTEV étaient dominés par: l’obésité (54,9%), l’alitement (25,5%) et le long voyage (17,6%). Les principaux symptômes étaient: dyspnée (98,0%), douleur thoracique (78,4%) et toux (60,8%). Le score de Wells était élevé dans 29,4%. L’ECG notait: tachycardie (78,4%), HVD (49,0%), aspect S1Q3T3 (47,1%) et bloc droit (39,2%). L’échodoppler cardiaque transthoracique montrait une dilatation cavitaire droite et thrombus intra ventriculaire droit dans 5,6%. L’angioscanner thoracique était normal dans 9,8% et objectivait un embole dans 82,4%. Le traitement était fait d’HBPM à dose curative avec relais par un AVK. Une thrombolyse était effectuée chez 8 malades. L’évolution était favorable dans 86,3%. Le taux de létalité était de 13,7%. Conclusion La prévalence de l’EP est relativement faible chez nous mais probablement sous estimée. L’EP pose un problème thérapeutique au Togo à cause du coût élevé des examens complémentaires et de la thrombolyse. La prévention reste donc l’arme efficace.
The Pan African medical journal | 2014
Findibé Damorou; Soodougoua Baragou; Machihuede Pio; Yaovi Afassinou; N’kenon W. N’da; Soulemane Pessinaba; Tchaa Tchérou; Halé Attiogbé; Koffi Ehlan; Edem Goeh-Akue; Komlavi Yayehd
The Pan African medical journal | 2014
Machihude Pio; Yaovi Afassinou; Soulemane Pessinaba; Soodougoua Baragou; Jacques N'djao; Borgatia Atta; Efadzi Ehlan; Findibé Damorou; Edem Goeh-Akue
The Pan African medical journal | 2012
S. Pessinaba; Komlavi Yayehd; Pio M; Baragou R; Yaovi Afassinou; Tchaa Tchérou; Findibé Damorou
The Pan African medical journal | 2014
Machihude Pio; Yaovi Afassinou; Soodougoua Baragou; Edem K. Goeh Akue; S. Pessinaba; Borgatia Atta; Koffi Ehlan; Amouzou Alate; Findibé Damorou
The Pan African medical journal | 2012
Soulemane Pessinaba; Komlavi Yayehd; Pio M; Réné Baragou; Yaovi Afassinou; Tchaa Tchérou; Findibé Damorou
The Pan African medical journal | 2011
Findibé Damorou; Komlavi Yayehd; Soulemane Pessinaba; Tchaa Tchérou; Johnson Amonu